In addition, potentially targetable mutations in PIK3CA, FGFR2, FGFR3, BRAF, HRAS, MAP2K1, PTEN, and NOTCH1 were found and could be associated with progressive disease [75], but further analyses are needed in sinonasal carcinomas. This evidence concerns the gene PTEN and nasal cavity and paranasal sinus carcinoma.